M
Michael H. Silber
Researcher at Mayo Clinic
Publications - 183
Citations - 13880
Michael H. Silber is an academic researcher from Mayo Clinic. The author has contributed to research in topics: REM sleep behavior disorder & Restless legs syndrome. The author has an hindex of 55, co-authored 172 publications receiving 12531 citations. Previous affiliations of Michael H. Silber include University of Rochester.
Papers
More filters
Journal ArticleDOI
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Diego Garcia-Borreguero,Michael H. Silber,John W. Winkelman,Birgit Högl,Jacquelyn L. Bainbridge,Mark J. Buchfuhrer,Georgios M. Hadjigeorgiou,Yuichi Inoue,Mauro Manconi,Wolfgang H. Oertel,William G. Ondo,Juliane Winkelmann,Richard P. Allen +12 more
TL;DR: Treatment of existing augmentation should be initiated, where possible, with the elimination/correction of extrinsic exacerbating factors (iron levels, antidepressants, antihistamines, etc.).
Journal ArticleDOI
REM Sleep Behavior Disorder in Parkinson’s Disease and Dementia with Lewy Bodies:
TL;DR: The evolving data suggests that RBD may have clinical diagnostic and pathophysiologic significance in isolation and when associated with neurodegenerative disease.
Journal ArticleDOI
Stridor and death in multiple system atrophy.
TL;DR: It is concluded that stridor does carry a poor prognosis in patients with MSA but that there are also other causes of death, including central hypoventilation and its complications.
Journal ArticleDOI
Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study
Jennifer R. Molano,Bradley F. Boeve,Tanis J. Ferman,Glenn E. Smith,Joseph E. Parisi,Dennis W. Dickson,David S. Knopman,Neill R. Graff-Radford,Yonas E. Geda,John A. Lucas,Kejal Kantarci,Maria Shiung,Clifford R. Jack,Michael H. Silber,V. Shane Pankratz,Ronald C. Petersen +15 more
TL;DR: Among Lewy body disease cases that pass through a mild cognitive impairment stage, any cognitive pattern or mild cognitive subtype is possible, with the attention/executive and visuospatial domains most frequently impaired.
Journal ArticleDOI
Treatment outcomes in REM sleep behavior disorder.
Stuart J. McCarter,Christopher L. Boswell,Erik K. St. Louis,Lucas G. Dueffert,Nancy L. Slocumb,Bradley F. Boeve,Michael H. Silber,Eric J. Olson,Maja Tippmann-Peikert +8 more
TL;DR: Melatonin and clonazepam were each reported to reduce RBD behaviors and injuries and appeared comparably effective in the authors' naturalistic practice experience.